Skip to content

Medical-device intelligence

NRI: Autoantibodies, Nuclear Pore Glycoprotein Gp210

FDA product code NRI: Autoantibodies, Nuclear Pore Glycoprotein Gp210. View classification details, related manufacturers, 510(k) clearances, and recall records.

FDA classification ↗

Classification details

Product code
NRI
FDA device name
Autoantibodies, Nuclear Pore Glycoprotein Gp210
Device class
2
Regulation number
866.5090
Medical specialty
Immunology
Review panel
IM

FDA definition

The device is used for the detection, in human serum or plasma, of autoantibodies to gp210 (nuclear pore glycoprotein gp210) as an aid in the diagnosis of primary biliary cirrhosis.
Explore immunology records →
A product code groups records by FDA classification. It does not establish identical intended uses, commercial availability, or comparative device safety.

Record activity in this scope

2 clearance records and 0 recall records in the covered releases, across 1 source company names and 1 product codes. Dated history runs from Jun 25, 2004 to Oct 18, 2006.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

Code and FDA device nameClearancesRecalls
NRI · Autoantibodies, Nuclear Pore Glycoprotein Gp21020

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

2 matching records
Device / recordCompany in FDA recordSourceSource date
QUANTA LITE PBC SCREEN IGG/IGA ELISAK061842 · NRIInova Diagnostics, Inc.510(k)Oct 18, 2006FDA decision date
QUANTA LITE GP210 ELISAK040885 · NRIInova Diagnostics, Inc.510(k)Jun 25, 2004FDA decision date

Manufacturers in these records

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 21, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 21, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗